Hospitals Sue Again to Halt 340B Rebate Pilot

· Health · United States

The American Hospital Association has filed a new lawsuit against the Trump administration over its plan to overhaul the federal 340B drug discount program, according to STAT. The dispute centers on a proposed structural change: instead of hospitals receiving upfront discounts on outpatient drugs, the program would shift to an after-the-fact rebate model. The AHA is seeking to halt the pilot. AHA is the industry's main hospital trade group. This is the second legal challenge to the plan. The 340B program requires drugmakers to offer discounted prices to eligible hospitals and clinics serving low-income patients; the proposed switch to rebates would alter the timing and mechanics of those savings, affecting hospital finances and drugmaker payments. Hospitals argue the change would undermine the program's purpose, while the administration frames it as a modernization.

Why it matters：The 340B program is a multi-billion-dollar channel for discounted medicines in the U.S., so any change to its payment mechanics directly affects hospital revenue and drugmaker net pricing, and the legal outcome could set a precedent for how federal drug discount programs are administered.

Key points

  • The AHA is suing the Trump administration for a second time over the 340B rebate pilot.
  • The proposal would replace upfront discounts with after-the-fact rebates for eligible hospitals and clinics.
  • The program requires drugmakers to give discounted prices to providers serving low-income patients.

Sources (original reporting)

More stories from this day